From: Microtubule S-glutathionylation as a potential approach for antimitotic agents
Cell line | IC50*(μM) |
---|---|
NCI/ADR-RES (ovarian cancer) | 28 ± 1 |
OVCAR-3 (ovarian cancer) | 33 ± 2 |
UACC-62 (melanoma) | 22 ± 1 |
SK-MEL-2 (melanoma) | 40 ± 9 |
NCI-H226 (lung cancer) | 68 ± 4 |
UO-31 (kidney cancer) | 44 ± 10 |
A431 (skin cancer) | 73 ± 4 |
PC-3 (prostate cancer) | 50 ± 12 |
MCF7 (breast cancer) | 75 ± 5 |
GC3/c1 (colon cancer) | 42 ± 1 |